
Advanced Enzyme Technologies Q3 Results 2026 Highlights: Net Profit Rises by 12.89% & Revenue Up 1.68% YoY
Click and Sign Up to Get Live Updates on Q3 Results
Updated: 1 Feb 2026 • 11:39 am
Posted by:

Advanced Enzyme Technologies Q3 Results FY26: During Q3 FY26, Advanced Enzyme Technologies' profit increased 12.89% YoY, while revenue increased by 1.68% YoY. The company posted robust numbers, with Q3 PAT at ₹42.50 crores and revenue at ₹171.95 crores. Advanced Enzyme Technologies showed its Q3 results on 31st January 2026.
Advanced Enzyme Technologies Q3 Results FY26: Extracts of FY25 & FY26
| Particulars | Consolidated Figures | Standalone Figures | ||
| 31st Dec 2025 | 31st Dec 2024 | 31st Dec 2025 | 31st Dec 2024 | |
| Revenue from Operations | ₹171.95 | ₹169.11 | ₹95.58 | ₹100.87 |
| Profit Before Tax (PBT) | ₹57.82 | ₹62.94 | ₹24.76 | ₹23.49 |
| Profit After Tax (PAT) | ₹42.50 | ₹37.65 | ₹13.25 | ₹15.18 |
Advanced Enzyme Technologies Q3 Results FY26 Highlights (Q3 FY26 vs FY25)
- Advanced Enzyme Technologies clocked Q3 FY26 consolidated revenue of ₹171.95 crores vs ₹169.11 crores.
- On the profit front, Advanced Enzyme Technologies earned a consolidated PAT of ₹42.50 crore in Q3 FY26. During FY25, the company’s PAT stood at ₹37.65 crore.
- According to the consolidated figures, Advanced Enzyme Technologies' quarterly PAT increased by 12.89% YoY, while revenue increased by 1.68%.
- Advanced Enzyme Technologies clocked Q3 FY26 standalone revenue of ₹95.58 crores vs ₹100.87 crores.
- On the profit front, Advanced Enzyme Technologies earned a standalone PAT of ₹13.25 crore in Q3 FY26. During FY25, the company’s PAT stood at ₹15.18 crore.
- According to the standalone figures, Advanced Enzyme Technologies' quarterly PAT decreased by12.75% YoY, while revenue decreased by 5.24%.
Download the Univest iOS App or Univest Android App to get daily stock recommendations and insightful research pieces!
Advanced Enzyme Technologies Share Price Performance
On the opening bell on 1st February 2026, Advanced Enzyme Technologies shares opened at ₹293.65 per share. However, the initial gains have since eroded, and Advanced Enzyme Technologies's shares are currently trading at ₹285.85 per share, which is lower than the opening price.
Considering the long-term performance, Advanced Enzyme Technologies shares have yielded returns of approximately -14.26% over the past year and -14.49% over the past 5 years. Over the maximum timeframe, Advanced Enzyme Technologies shares delivered a 0.37% return to investors.
What Analysts Expect Post Q3 Results?
Following Advanced Enzyme Technologies's robust Q3 results for FY26, analysts expect its share price to rise. According to analysts, Advanced Enzyme Technologies's share price could reach ₹365.80 per share in the coming year and, in a downturn, could hit ₹269.80 per share. However, one must ignore stock market volatility and invest in Advanced Enzyme Technologies's shares after thorough research.
Disclaimer: Investment in the share market is subject to risk. This news article is for informational purposes only. Conduct your own research before investing in shares and other securities.
Recent Articles
Moschip Technologies Gears Up for Q3 Reveal on 31st January; Check Key Expectations Here
Meghmani Organics Gears Up for Q3 Reveal on 31st January; Check Key Expectations Here
MIC Electronics Gears Up for Q3 Reveal on 31st January; Check Key Expectations Here
Indo Rama Synthetics (India) Gears Up for Q3 Reveal on 31st January; Check Key Expectations Here
Garware Hi-Tech Films Gears Up for Q3 Reveal on 31st January; Check Key Expectations Here
ASM Technologies Gears Up for Q3 Reveal on 31st January; Check Key Expectations Here
Recent Articles

Top Stocks to Buy for Long Term: Bharti Airtel, Kotak Bank, Eternal Among 9 Stocks Experts Suggest, Check Target Price
13 October 2026

Hong Kong Stock Market: Hang Seng Index Recovers From Intraday Losses, Extends Gains for 3rd Day, What Gave It a Boost?
13 October 2026

Ramkrishna Forgings Share Price Up 34% in 2026: Monarch Networth Sees 18% Upside With Rs 806 Target, Here's Why
13 October 2026

RIL Target Price Ahead of Jio Initial Public Offering: 47% Upside, Why Religare Recommends Buying the Mukesh Ambani Stock Before Issue Launch
13 October 2026
Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.
Reviews
Recent Posts
Top Stocks to Buy for Long Term: Bharti Airtel, Kotak Bank, Eternal Among 9 Stocks Experts Suggest, Check Target Price
Hong Kong Stock Market: Hang Seng Index Recovers From Intraday Losses, Extends Gains for 3rd Day, What Gave It a Boost?
Ramkrishna Forgings Share Price Up 34% in 2026: Monarch Networth Sees 18% Upside With Rs 806 Target, Here's Why
RIL Target Price Ahead of Jio Initial Public Offering: 47% Upside, Why Religare Recommends Buying the Mukesh Ambani Stock Before Issue Launch
Moneyview Share Price: Newly Listed Stock Gives 83% Returns in 13 Days, Should You Hold for More Gains or Book Profits?
Popular this week
Up 75% in 6 Months, India Glycols Shares Surge 14% Today: Should You Buy? Experts Decode the India Glycols Share Price Rally

Uniresearch Global Pvt Ltd
Research Analyst
SEBI Registration Number — INH000013776
Uniresearch is a subsidiary of Univest Communication Technologies Private Limited
Company Address: Registered Address: Ground Floor, Unitech Commercial Tower 2, Block B, Greenwood City, Unit 1-3, Sector 45, Gurugram, Haryana 122003
Write to us : support@univest.in, compliance@univest.in
Verify on SEBI registry →RESEARCH ANALYST
Get SEBI Registered
advice on the stocks
trending today.
Get 3 FREE Trade Ideas
for Startups Accelerator 2024
Trusted by 1Cr Indians
Awarded No.1 by Economic Times





